ACTOplus met FDA Approval History
FDA Approved: Yes (First approved August 29, 2005)
Brand name: ACTOplus met
Generic name: pioglitazone and metformin
Dosage form: Tablets
Company: Takeda Pharmaceuticals
Treatment for: Diabetes, Type 2
ACTOplus met (pioglitazone and metformin) is a combination antihyperglycemic medication used in the management of type 2 diabetes.
Development timeline for ACTOplus met
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.